Astrana Health, Inc. (ASTH) vs Trevi Therapeutics, Inc. (TRVI)

A side-by-side comparison of Astrana Health, Inc. and Trevi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Astrana Health, Inc. logo
ASTH
Astrana Health, Inc.
$1.83B
$37.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Trevi Therapeutics, Inc. logo
TRVI
Trevi Therapeutics, Inc.
$1.87B
$13.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ASTH vs TRVI

growth of $100 · dividends reinvested · last 7y
ASTH +85.0% (+9.2%/yr)TRVI +73.9% (+8.2%/yr)ASTH compounded faster over this window
0200400600Start $100202120232025$185$174
ASTH TRVI

ASTH vs TRVI: by the numbers

  • •TRVI is the larger company ($1.87B vs $1.83B market cap).
  • •ASTH is profitable (1.05% net margin) while TRVI runs a net loss (0.00%).

Metrics side by side

Valuation

MetricASTHTRVI
P/E ratio45.26N/A
Forward P/E26.47N/A
P/S ratio0.48N/A
P/B ratio2.215.82
EV / EBITDA13.48N/A
FCF yield8.64%N/A

Profitability

MetricASTHTRVI
Gross margin9.22%0.00%
Operating margin2.61%0.00%
Net margin1.05%0.00%
ROE4.88%-15.90%
ROIC4.13%-18.51%

Growth (annualized)

MetricASTHTRVI
Revenue CAGR (5Y)53.77%N/A
EPS CAGR (5Y)-15.06%N/A
FCF CAGR (5Y)18.35%N/A
Total return CAGR (5Y)-16.52%61.74%

Frequently asked

Is ASTH or TRVI more profitable?
ASTH runs the higher net margin — ASTH at 1.05% versus TRVI at 0.00%.
How have ASTH and TRVI total returns compared?
Over the past 5 years, ASTH delivered -16.52% and TRVI delivered 61.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ASTH analysisFull TRVI analysisInteractive comparison tool

Dig into the metrics

Astrana Health P/E ratioAstrana Health ROETrevi Therapeutics ROEAstrana Health operating marginTrevi Therapeutics operating marginAstrana Health revenue growthTrevi Therapeutics revenue growthAstrana Health free cash flowTrevi Therapeutics free cash flow

Astrana Health & Trevi Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest FCF Yield StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.